Form 8-K - Current report:
SEC Accession No. 0001104659-25-002842
Filing Date
2025-01-13
Accepted
2025-01-13 07:00:38
Documents
51
Period of Report
2025-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253087d1_8k.htm   iXBRL 8-K 25818
2 EXHIBIT 99.1 tm253087d1_ex99-1.htm EX-99.1 32367
3 EXHIBIT 99.2 tm253087d1_ex99-2.htm EX-99.2 53596
7 GRAPHIC tm253087d1_ex99-1img001.jpg GRAPHIC 3632
8 GRAPHIC tm253087d1_ex99-2img001.jpg GRAPHIC 157534
9 GRAPHIC tm253087d1_ex99-2img002.jpg GRAPHIC 360652
10 GRAPHIC tm253087d1_ex99-2img003.jpg GRAPHIC 139273
11 GRAPHIC tm253087d1_ex99-2img004.jpg GRAPHIC 168592
12 GRAPHIC tm253087d1_ex99-2img005.jpg GRAPHIC 114836
13 GRAPHIC tm253087d1_ex99-2img006.jpg GRAPHIC 165926
14 GRAPHIC tm253087d1_ex99-2img007.jpg GRAPHIC 133823
15 GRAPHIC tm253087d1_ex99-2img008.jpg GRAPHIC 109859
16 GRAPHIC tm253087d1_ex99-2img009.jpg GRAPHIC 176168
17 GRAPHIC tm253087d1_ex99-2img010.jpg GRAPHIC 143548
18 GRAPHIC tm253087d1_ex99-2img011.jpg GRAPHIC 95054
19 GRAPHIC tm253087d1_ex99-2img012.jpg GRAPHIC 153157
20 GRAPHIC tm253087d1_ex99-2img013.jpg GRAPHIC 129765
21 GRAPHIC tm253087d1_ex99-2img014.jpg GRAPHIC 142626
22 GRAPHIC tm253087d1_ex99-2img015.jpg GRAPHIC 151458
23 GRAPHIC tm253087d1_ex99-2img016.jpg GRAPHIC 134942
24 GRAPHIC tm253087d1_ex99-2img017.jpg GRAPHIC 91980
25 GRAPHIC tm253087d1_ex99-2img018.jpg GRAPHIC 189665
26 GRAPHIC tm253087d1_ex99-2img019.jpg GRAPHIC 131119
27 GRAPHIC tm253087d1_ex99-2img020.jpg GRAPHIC 124761
28 GRAPHIC tm253087d1_ex99-2img021.jpg GRAPHIC 101962
29 GRAPHIC tm253087d1_ex99-2img022.jpg GRAPHIC 146961
30 GRAPHIC tm253087d1_ex99-2img023.jpg GRAPHIC 168012
31 GRAPHIC tm253087d1_ex99-2img024.jpg GRAPHIC 162370
32 GRAPHIC tm253087d1_ex99-2img025.jpg GRAPHIC 158032
33 GRAPHIC tm253087d1_ex99-2img026.jpg GRAPHIC 114983
34 GRAPHIC tm253087d1_ex99-2img027.jpg GRAPHIC 118920
35 GRAPHIC tm253087d1_ex99-2img028.jpg GRAPHIC 126409
36 GRAPHIC tm253087d1_ex99-2img029.jpg GRAPHIC 205862
37 GRAPHIC tm253087d1_ex99-2img030.jpg GRAPHIC 113446
38 GRAPHIC tm253087d1_ex99-2img031.jpg GRAPHIC 114196
39 GRAPHIC tm253087d1_ex99-2img032.jpg GRAPHIC 111101
40 GRAPHIC tm253087d1_ex99-2img033.jpg GRAPHIC 106314
41 GRAPHIC tm253087d1_ex99-2img034.jpg GRAPHIC 54040
42 GRAPHIC tm253087d1_ex99-2img035.jpg GRAPHIC 230618
  Complete submission text file 0001104659-25-002842.txt   7254822

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fold-20250112.xsd EX-101.SCH 3045
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20250112_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20250112_pre.xml EX-101.PRE 22379
53 EXTRACTED XBRL INSTANCE DOCUMENT tm253087d1_8k_htm.xml XML 3552
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 25524744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)